S
Suoqun Zhao
Publications - 4
Citations - 7
Suoqun Zhao is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 4 publications receiving 7 citations.
Papers
More filters
Journal ArticleDOI
Rational development of multicomponent mRNA vaccine candidates against mpox
Rong Rong Zhang,Zheng-Jian Wang,Yilong Zhu,W Tang,Chao Zhou,Suoqun Zhao,Meiting Wu,Tao Ming,Yong-Qiang Deng,Qi Chen,Ning Jin,Qing Ye,Xiao Li,Cheng-Feng Qin +13 more
TL;DR: Based on the established lipid nanoparticle (LNP)-encapsulated mRNA vaccine platform, the authors rationally constructed and prepared a panel of multicomponent MPXV vaccine candidates encoding different combinations of viral antigens.
Journal ArticleDOI
An Engineered IgG–VHH Bispecific Antibody against SARS‐CoV‐2 and Its Variants
Hang Chi,Lei Wang,Chanjuan Liu,Xiaohe Cheng,Hailiang Zheng,Lilang Lv,Yong Chiang Tan,Na-Na Zhang,Suoqun Zhao,Meiting Wu,D. Luo,Hong-Ying Qiu,Rui Feng,Wangjun Fu,Jie Zhang,Xiaochuan Xiong,Yifei Zhang,Shulong Zu,Qi Chen,Qing Ye,Xintian Yan,Yu-hong Hu,Zhen Zhang,Run-lin Yan,Jiangfeng Yin,Pan Lei,Wanjing Wang,Guojun Lang,Junbing Shao,Yong-Qiang Deng,Xiangxi Wang,Chengfeng Qin +31 more
TL;DR: Results demonstrate that the novel bsAb format is feasible and effective, suggesting great potential as an inspiring antiviral strategy, and shows potent prophylactic and therapeutic efficacy against SARS-CoV-2 in three established mouse models.
Journal ArticleDOI
PA-E18G substitution in influenza A virus confers resistance to ZX-7101, a cap-dependent endonuclease inhibitor.
D. Luo,Qing Ye,Ruiting Li,Hangyu Zhou,Jingjing Guo,Suoqun Zhao,Sen Zhang,Tao Jiang,Yong-Qiang Deng,Cheng-Feng Qin +9 more
TL;DR: In this article , the authors comprehensively characterized the in vitro and in vivo antiviral activities of ZX-7101A, an analogue of baloxavir marboxil (BXM), and identified a novel amino acid substitution responsible for CEN inhibitor resistance.
Journal ArticleDOI
Application of nucleic acid-encoded antibodies in prevention and treatment of emerging viral infectious diseases
TL;DR: In this article , the authors summarized the principles and current research status of nucleic acid-encoded antibodies in antiviral control and highlight the advantages of NAs over traditional protein antibodies, the advantages and disadvantages of different NAs, and the potential challenges and possible strategies for the future development of these agents.